The ratings assignment is based on a number of factors, including CHLA’s strong brand name and reputation for clinical and research excellence.
The outlook is stable, reflecting Moody’s Investors Service’s expectation CHLA’s cash flow will grow during the next several years as the organization implements its performance improvement plans.
More articles on healthcare finance:
Moody’s assigns ‘Baa2’ rating to Eisenhower Medical Center’s bonds
Moody’s affirms ‘Baa2’ rating on Exeter Hospital’s bonds
Moody’s affirms ‘A2′ rating on University Hospitals’ bonds
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.